Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antitumor impact of p14ARF on gefitinib-resistant non-small cell lung cancers.
Saito K, Takigawa N, Ohtani N, Iioka H, Tomita Y, Ueda R, Fukuoka J, Kuwahara K, Ichihara E, Kiura K, Kondo E. Saito K, et al. Among authors: fukuoka j. Mol Cancer Ther. 2013 Aug;12(8):1616-28. doi: 10.1158/1535-7163.MCT-12-1239. Epub 2013 Jun 12. Mol Cancer Ther. 2013. PMID: 23761220
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403).
Tamura K, Okamoto I, Kashii T, Negoro S, Hirashima T, Kudoh S, Ichinose Y, Ebi N, Shibata K, Nishimura T, Katakami N, Sawa T, Shimizu E, Fukuoka J, Satoh T, Fukuoka M; West Japan Thoracic Oncology Group. Tamura K, et al. Among authors: fukuoka m, fukuoka j. Br J Cancer. 2008 Mar 11;98(5):907-14. doi: 10.1038/sj.bjc.6604249. Epub 2008 Feb 19. Br J Cancer. 2008. PMID: 18283321 Free PMC article. Clinical Trial.
Malignant pleural effusion from lung adenocarcinoma treated by gefitinib.
Kubo A, Koh Y, Kawaguchi T, Isa S, Okamoto I, Fukuoka J, Kusunoki Y, Kitaichi M, Takada M, Nakagawa K. Kubo A, et al. Among authors: fukuoka j. Intern Med. 2011;50(7):745-8. doi: 10.2169/internalmedicine.50.4652. Epub 2011 Apr 1. Intern Med. 2011. PMID: 21467709 Free article.
Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia.
Ogura T, Takigawa N, Tomii K, Kishi K, Inoue Y, Ichihara E, Homma S, Takahashi K, Akamatsu H, Ikeda S, Inase N, Iwasawa T, Ohe Y, Ohta H, Onishi H, Okamoto I, Ogawa K, Kasahara K, Karata H, Kishimoto T, Kitamura Y, Gemma A, Kenmotsu H, Sakashita H, Sakamoto S, Sekine K, Takiguchi Y, Tada Y, Toyooka S, Nakayama Y, Nishioka Y, Hagiwara K, Hanibuchi M, Fukuoka J, Minegishi Y, Yanagihara T, Yamamoto N, Yamamoto H, Gaga M, Fong KM, Powell CA, Kiura K; DLD/TO Assemblies of JRS. Ogura T, et al. Among authors: fukuoka j. Respir Investig. 2019 Nov;57(6):512-533. doi: 10.1016/j.resinv.2019.06.001. Epub 2019 Aug 1. Respir Investig. 2019. PMID: 31377122 Review.
Inactivation of LLC1 gene in nonsmall cell lung cancer.
Hong KM, Yang SH, Chowdhuri SR, Player A, Hames M, Fukuoka J, Meerzaman D, Dracheva T, Sun Z, Yang P, Jen J. Hong KM, et al. Among authors: fukuoka j. Int J Cancer. 2007 Jun 1;120(11):2353-8. doi: 10.1002/ijc.22577. Int J Cancer. 2007. PMID: 17304513 Free PMC article.
279 results